Cargando…

The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression

BACKGROUND: The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1), are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupouy, Sandra, Viardot-Foucault, Véronique, Alifano, Marco, Souazé, Frédérique, Plu-Bureau, Geneviève, Chaouat, Marc, Lavaur, Anne, Hugol, Danielle, Gespach, Christian, Gompel, Anne, Forgez, Patricia
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626627/
https://www.ncbi.nlm.nih.gov/pubmed/19156213
http://dx.doi.org/10.1371/journal.pone.0004223
_version_ 1782163459039821824
author Dupouy, Sandra
Viardot-Foucault, Véronique
Alifano, Marco
Souazé, Frédérique
Plu-Bureau, Geneviève
Chaouat, Marc
Lavaur, Anne
Hugol, Danielle
Gespach, Christian
Gompel, Anne
Forgez, Patricia
author_facet Dupouy, Sandra
Viardot-Foucault, Véronique
Alifano, Marco
Souazé, Frédérique
Plu-Bureau, Geneviève
Chaouat, Marc
Lavaur, Anne
Hugol, Danielle
Gespach, Christian
Gompel, Anne
Forgez, Patricia
author_sort Dupouy, Sandra
collection PubMed
description BACKGROUND: The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1), are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series of transforming functions including cellular migration and invasion. METHODS AND RESULTS: we investigated the expression of NTS and NTSR1 in normal human breast tissue and in invasive ductal breast carcinomas (IDCs) by immunohistochemistry and RT-PCR. NTS is expressed and up-regulated by estrogen in normal epithelial breast cells. NTS is also found expressed in the ductal and invasive components of IDCs. The high expression of NTSR1 is associated with the SBR grade, the size of the tumor, and the number of metastatic lymph nodes. Furthermore, the NTSR1 high expression is an independent factor of prognosis associated with the death of patients. CONCLUSION: these data support the activation of neurotensinergic deleterious pathways in breast cancer progression.
format Text
id pubmed-2626627
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-26266272009-01-19 The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression Dupouy, Sandra Viardot-Foucault, Véronique Alifano, Marco Souazé, Frédérique Plu-Bureau, Geneviève Chaouat, Marc Lavaur, Anne Hugol, Danielle Gespach, Christian Gompel, Anne Forgez, Patricia PLoS One Research Article BACKGROUND: The neurotensin (NTS) and its specific high affinity G protein coupled receptor, the NT1 receptor (NTSR1), are considered to be a good candidate for one of the factors implicated in neoplastic progression. In breast cancer cells, functionally expressed NT1 receptor coordinates a series of transforming functions including cellular migration and invasion. METHODS AND RESULTS: we investigated the expression of NTS and NTSR1 in normal human breast tissue and in invasive ductal breast carcinomas (IDCs) by immunohistochemistry and RT-PCR. NTS is expressed and up-regulated by estrogen in normal epithelial breast cells. NTS is also found expressed in the ductal and invasive components of IDCs. The high expression of NTSR1 is associated with the SBR grade, the size of the tumor, and the number of metastatic lymph nodes. Furthermore, the NTSR1 high expression is an independent factor of prognosis associated with the death of patients. CONCLUSION: these data support the activation of neurotensinergic deleterious pathways in breast cancer progression. Public Library of Science 2009-01-19 /pmc/articles/PMC2626627/ /pubmed/19156213 http://dx.doi.org/10.1371/journal.pone.0004223 Text en Dupouy et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dupouy, Sandra
Viardot-Foucault, Véronique
Alifano, Marco
Souazé, Frédérique
Plu-Bureau, Geneviève
Chaouat, Marc
Lavaur, Anne
Hugol, Danielle
Gespach, Christian
Gompel, Anne
Forgez, Patricia
The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title_full The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title_fullStr The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title_full_unstemmed The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title_short The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
title_sort neurotensin receptor-1 pathway contributes to human ductal breast cancer progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626627/
https://www.ncbi.nlm.nih.gov/pubmed/19156213
http://dx.doi.org/10.1371/journal.pone.0004223
work_keys_str_mv AT dupouysandra theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT viardotfoucaultveronique theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT alifanomarco theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT souazefrederique theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT plubureaugenevieve theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT chaouatmarc theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT lavauranne theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT hugoldanielle theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT gespachchristian theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT gompelanne theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT forgezpatricia theneurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT dupouysandra neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT viardotfoucaultveronique neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT alifanomarco neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT souazefrederique neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT plubureaugenevieve neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT chaouatmarc neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT lavauranne neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT hugoldanielle neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT gespachchristian neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT gompelanne neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression
AT forgezpatricia neurotensinreceptor1pathwaycontributestohumanductalbreastcancerprogression